Related by context. Frequent words. (Click for all words.) 61 MAA submission 61 Receives Orphan Drug Designation 60 orphan designation 60 TEMODAL 60 Plenaxis R 60 Kepivance 60 ISTODAX 60 TRISENOX 60 Phase III Clinical Trial 60 KRN# 59 CLIA waiver 59 ATryn ® 59 rilonacept 59 THALOMID 58 Pivotal Phase III 58 Soliris TM eculizumab 58 Tacrolimus 58 Acute Ischemic Stroke 58 cinacalcet 58 Pivotal Trial 58 AZILECT R 58 TYGACIL 58 forodesine 58 subcutaneous formulation 58 Octreotide 58 Initiates Phase II 58 VALSTAR 57 orBec 57 Combidex 57 Investigational Device Exemption 57 alvimopan 57 mesylate 57 NOXAFIL 57 FDA Accepts 57 Orphan Drug Status 57 Fibrillex TM 57 Panzem R 57 Rhucin R 57 filgrastim 57 Cethrin 57 PRIALT 57 FM VP4 56 Aquavan 56 amrubicin 56 Accelerated Approval 56 PROVIGIL 56 NEBIDO 56 FDA Complete Response 56 BEXXAR 56 MoxDuo IR 56 PROMACTA 56 GRNVAC1 56 Alzhemed TM 56 NeutroSpec 56 vismodegib 56 Meets Primary Endpoint 56 TELINTRA 56 Retisert 56 Orphan Drug status 56 Marketing Authorization 56 Amrubicin 56 Ticagrelor 56 FIRAZYR 56 JAK inhibitor 56 OsmoPrep 56 Oxaliplatin 56 URG# 56 ARCOXIA 56 Marketing Authorisation 56 HepeX B 56 Trofex 56 Single Dose 56 confirmatory Phase III 56 Virulizin R 56 Bioequivalence 55 Urocidin 55 Onsolis 55 Angiox 55 orphan medicinal product 55 Eculizumab 55 oral anticoagulant 55 Australian Therapeutic Goods 55 CHMP recommendation 55 Aerosurf 55 Roflumilast 55 IND submission 55 Icatibant 55 NeuVax 55 Anturol 55 Scientific Advice 55 pafuramidine 55 Exelon Patch 55 Presents Positive 55 Complete Response 55 ROTATEQ 55 Phase III Trial 55 Milnacipran 55 ONTAK 55 Alferon N Injection 55 Pivotal Study 55 EMSAM